The DOI matches its Crossref record; 191 of the 193 references it cites were found in a registry or an index.
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Open accessAbstract
The incidence and prevalence of diabetes mellitus have grown significantly throughout the world, due primarily to the increase in type 2 diabetes. This overall increase in the number of people with diabetes has had a major impact on development of diabetic kidney disease (DKD), one of the most frequent complications of both types of diabetes. DKD is the leading cause of end-stage renal disease (ESRD), accounting for approximately 50% of cases in the developed world. Although incidence rates for ESRD attributable to DKD have recently stabilized, these rates continue to rise in high-risk groups such as middle-aged African Americans, Native Americans, and Hispanics. The costs of care for people with DKD are extraordinarily high. In the Medicare population alone, DKD-related expenditures among this mostly older group were nearly $25 billion in 2011. Due to the high human and societal costs, the Consensus Conference on Chronic Kidney Disease and Diabetes was convened by the American Diabetes Association in collaboration with the American Society of Nephrology and the National Kidney Foundation to appraise issues regarding patient management, highlighting current practices and new directions. Major topic areas in DKD included 1) identification and monitoring, 2) cardiovascular disease and management of dyslipidemia, 3) hypertension and use of renin-angiotensin-aldosterone system blockade and mineralocorticoid receptor blockade, 4) glycemia measurement, hypoglycemia, and drug therapies, 5) nutrition and general care in advanced-stage chronic kidney disease, 6) children and adolescents, and 7) multidisciplinary approaches and medical home models for health care delivery. This current state summary and research recommendations are designed to guide advances in care and the generation of new knowledge that will meaningfully improve life for people with DKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A1C levels are also less reliable at advanced CKD stages (64,65).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“A1C levels are also less reliable at advanced CKD stages (63,64).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [63]
In the citing paper
“There is no evidence that adjusting the daily level of protein intake (typically 1-1.5 g/kg body wt/day or 15-20% total calories) will improve health, and research is inconclusive regarding the ideal amount of dietary protein to optimize either glycemic management or CVD risk (159,195).”
From 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023 (2023) · cites this paper as [195]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedAhmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Self-citationBrenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Adherence to Long-Term Therapies: Evidence for Action
Geest, S. D., & Sabate, E. J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,310
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Cited by
Sorted by citations
Items 501–600 of 1,000
Pyruvate Kinase M2: A New Biomarker for the Early Detection of Diabetes-Induced Nephropathy
Park, Y. S., Han, J. H., Park, J. H., Choi, J. S., Kim, S. H., & Kim, H. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032683 · Cited by 13
Doi, Y., Hamano, T., Yamaguchi, S., Sakaguchi, Y., Kaimori, J., & Isaka, Y. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15191 · Cited by 13
Glycemic status and chronic kidney disease in C hinese adults: F indings from the REACTION study
Lin, L., Lu, J., Chen, L., Mu, Y., Ye, Z., Liu, C., Chen, G., Shi, L., Zhao, J., Li, Q., et al. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12490 · Cited by 13
Fang, J., Yang, Y., Zhang, Z., Jiang, S., Yu, T., & Li, W. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2019.12.008 · Cited by 13
Hieshima, K., Suzuki, T., Sugiyama, S., Kurinami, N., Yoshida, A., MIYAMOTO, F., Kajiwara, K., Jinnouchi, T., & Jinnouchi, H. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3400w · Cited by 13
Does the Mediterranean diet reduce the odds of diabetic nephropathy in women? A case–control study
Noori, S., Mirzababaei, A., Abaj, F., Ghaffarian-Ensaf, R., & Mirzaei, K. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.984622 · Cited by 12
Lee, H., Kim, H., Jeon, J. S., Noh, H., Park, R., Byun, D. W., Kim, H. J., Suh, K., Park, H. K., & Kwon, S. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-22083-6 · Cited by 12
Torres, Á., Nahuelpán, Y., Muñoz, K., Jara, C., Cappelli, C., Taracha-Wiśniewska, A., Quezada-Monrás, C., & Martín, R. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310829 · Cited by 12
Liu, C., Zhang, J., Wei, X., Shi, J., Fang, Q., Zhou, W., Sun, L., Hu, Z., Hong, J., Gu, W., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1278665 · Cited by 12
Zeng, G., Lin, Y., Xie, P., Lin, J., He, Y., & Wei, J.-P. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s465317 · Cited by 12
Plasma metals, genetic risk, and rapid kidney function decline among type 2 diabetes
Wang, R., Cheng, X., Long, T., Jia, C., Xu, Y., Wei, Y., Zhang, Y., He, X., & He, M. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.174069 · Cited by 12
Zheng, Y., Xu, C., & Jin, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1398382 · Cited by 12
The impact of severe hypoglycemia on renal impairment in type 2 diabetes
Lee, Y.-L., Chen, B., Lin, K., Su, R.-W., Lee, M., Hsiao, P., & Shin, S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.028 · Cited by 15
Bariatric and metabolic surgery and microvascular complications of type 2diabetes mellitus
COHEN, R. V., Pechy, F. N. Q., Petry, T. B. Z., Correa, J. L., Caravatto, P. P. D. P., & Tzanno‐Martins, C. (2015) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20150061 · Cited by 12
Rhee, C. M., Kovesdy, C. P., Ravel, V., Streja, E., Sim, J. J., You, A. S., Gatwood, J. D., Amin, A., Molnar, M. Z., Nguyen, D. V., et al. (2018) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2018.07.003 · Cited by 12
Self-citationRuiz, S., Amor, A. J., Pané, A., Andújar, A. M., Montagud‐Marrahí, E., Ventura‐Aguiar, P., Ferrer, J., & Esmatjes, E. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108135 · Cited by 13
Zheng, W., Ocorr, K. A., & Tatar, M. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.041301 · Cited by 12
Liao, P.-Y., Lo, H., Liu, I.-C., Lo, L.-C., Hsiang, C., & Ho, T. (2021) · Food & Function · doi:10.1039/d1fo03620c · Cited by 12
Luo, Q., Xia, X., Luo, Q., Qiu, Y., Dong, L., Zhao, C. N., Peng, F., Yu, J., Huang, F., & He, F. (2022) · Kidney Diseases · doi:10.1159/000523847 · Cited by 12
Role of Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Alexandrou, M. E., Theodorakopoulou, M. P., & Sarafidis, P. A. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2020019 · Cited by 12
Hsu, W.-C., Lin, C., Chen, J., & Chang, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092653 · Cited by 13
Comprehensive Diagnostics of Diabetic Nephropathy by Transcriptome RNA Sequencing
Lei, L., Bai, Y.-H., Fan, Y., Li, Y., Jiang, H., & Wang, J. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s371026 · Cited by 12
Chu, X., Feng, B., Ge, J., Guo, L., Huo, Y., Ji, L., Jia, Q., Jiang, S., Li, Y., Liu, F., et al. (2022) · Cardiology Plus · doi:10.1097/cp9.0000000000000029 · Cited by 12
Circulating Biomarkers to Predict Diabetic Retinopathy in Patients with Diabetic Kidney Disease
Jonny, J., Violetta, L., Kartasasmita, A., Supriyadi, R., & Rita, C. (2023) · Vision · doi:10.3390/vision7020034 · Cited by 12
Guo, M., Niu, J., Li, S., Ye, X., Fang, H., Zhao, Y.-P., & Gu, Y. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.08.016 · Cited by 12
Lin, C., Tsai, F., Chen, Y., Lee, H., Chen, S., Liu, K., & Lin, P.-J. (2016) · Medicine · doi:10.1097/md.0000000000002576 · Cited by 12
Corsonello, A., Pedone, C., Bandinelli, S., Ferrucci, L., & Incalzi, R. A. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12932 · Cited by 12
Non‐diabetic renal disease in patients with type 2 diabetes: a single centre study
Fan, J., & Wang, R. (2017) · Internal Medicine Journal · doi:10.1111/imj.13708 · Cited by 12
Kim, Y. A., Lee, Y., & Seo, J. H. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9806790 · Cited by 12
Piao, C., Zhang, Q., Jin, D., Wang, L., Tang, C. W., Zhang, N., Lian, F., & Tong, X. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6754761 · Cited by 12
Wang, C.-P., Lu, Y., Hung, W., Tsai, I., Chang, Y., Hu, D.-W., Hsu, C., Wu, C. C., Wei, C.-T., Chung, F., et al. (2021) · Public Health · doi:10.1016/j.puhe.2020.02.007 · Cited by 12
Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
Akpınar, K., Aslan, D., & Fenkçi, S. M. (2021) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2020-0145 · Cited by 12
Lira, A. L. D. A., Santana, M. D. F. M., Pinto, R. D. S., Minanni, C. A., Iborra, R. T., de Lima, A. M. S., Corrêa‐Giannella, M. L., Passarelli, M., & Queiroz, M. S. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107969 · Cited by 12
Renal phospholipidosis and impaired magnesium handling in high‐fat‐diet–fed mice
Kurstjens, S., Smeets, B., Bos, C., Dijkman, H. B. P. M., den Braanker, D. J. W., de Bel, T., Bindels, R. J. M., Tack, C. J., Hoenderop, J. G. J., & de Baaij, J. H. F. (2019) · The FASEB Journal · doi:10.1096/fj.201801778rr · Cited by 12
Monitoring Glycemic Control in End-Stage Renal Disease: What Should Be Measured?
Selvin, E., & Sacks, D. B. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.265744 · Cited by 13
Blood Pressure Control and Cardiovascular/Renal Outcomes
Dojki, F. K., & Bakris, G. L. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.008 · Cited by 11
Self-citationAli, A. S., Pham, C., Morahan, G., & Ekinci, E. I. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad704 · Cited by 11
Yang, W., Zhong, Y., Zhou, P., & Lu, D. (2025) · Renal Failure · doi:10.1080/0886022x.2024.2438846 · Cited by 11
Liu, J., Liu, S., Choo, R. W. M., Wee, S. L., Xu, A., & Lim, S. C. (2018) · Diabetic Medicine · doi:10.1111/dme.13641 · Cited by 11
Clemens, K. K., Ouédraogo, A. M., Nash, D. M., Garg, A. X., & Shariff, S. Z. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.06.005 · Cited by 11
Lu, C., Ma, J., Su, J., Wang, X., Liu, W., & Ge, X. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0039 · Cited by 11
Jiang, L., Zhou, J., Zhang, L., Du, Y., Jiang, M., Xie, L., Ma, Z., & Chen, F. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10035-7 · Cited by 11
Zhou, D., Wei, J., Zhang, T., Shen, F., & Yang, J.-K. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s357357 · Cited by 11
REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease
Wang, X., Wu, H., Yang, G., Xiang, J., Xiong, L., Zhao, L., Liao, T., Zhao, X., Kang, L., Yang, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.935796 · Cited by 11
Hansen, R. B., Falasinnu, T., Faurschou, M., Jacobsen, S., & Simard, J. F. (2023) · Arthritis Care & Research · doi:10.1002/acr.25091 · Cited by 11
Zhang, X., Huang, Y., Xu, N., Feng, W., Qiao, J., & Liu, M. R. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13997 · Cited by 11
Nielsen, S., Nyvad, J. T., Christensen, K. L., Poulsen, P. L., Laugesen, E., Grove, E. L., & Buus, N. H. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.06.076 · Cited by 11
Baldimtsi, E., Whiss, P. A., & Wahlberg, J. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108635 · Cited by 11
Taguchi, S., Azushima, K., Yamaji, T., Suzuki, T., Abe, E., Tanaka, S., Hirota, K., Tsukamoto, S., Morita, R., Kobayashi, R., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01496-4 · Cited by 11
Zhang, K., Zhang, W., Xia, F., Wang, N., Lu, Y., Sui, C., & Wang, B. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s436046 · Cited by 11
White, B., Ng, S. M., Agwu, J. C., Barrett, T. G., Birchmore, N., Kershaw, M., Drew, J., Kavvoura, F. K., Law, J., Moudiotis, C., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03349-4 · Cited by 12
Treatment urgency: The importance of getting people with type 2 diabetes to target promptly
Felton, A.-M., LaSalle, J. R., & McGill, M. J. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.026 · Cited by 11
Mori, K., Emoto, M., Shoji, T., & Inaba, M. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000265 · Cited by 11
Huang, K., Ma, Y., Wang, J., Shi, S., Fu, L., Liu, J., Li, L., Lu, H., Liang, X., Liu, Y., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.02.006 · Cited by 11
Balkau, B., Metzger, M., Andréelli, F., Frimat, L., Speyer, É., Combe, C., Laville, M., Jacquelinet, C., Briançon, S., Ayav, C., et al. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.03.007 · Cited by 11
Lee, Y.-L., Yen, S., Shin, S., Huang, Y.-C., He, J. S., & Lin, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16050681 · Cited by 12
Handelsman, Y., Muskiet, M. H. A., & Meneilly, G. S. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01126-x · Cited by 12
Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?
MacIsaac, R. J. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00863-5 · Cited by 11
Alicic, R. Z., Johnson, E. J., & Tuttle, K. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00003-3 · Cited by 11
Self-citationDonor-related diabetic nephropathy: a comprehensive clinicopathological study
Truong, L. D., Gaber, L. W., & Khan, F. N. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.10.032 · Cited by 11
Farida, L. S., Thaha, M., & Susanti, D. (2018) · Biomolecular and Health Science Journal · doi:10.20473/bhsj.v1i2.9400 · Cited by 11
Lu, J., Zhao, W., Chen, T., Xu, Z., Sun, X., Xie, H., An, Y., Zeng, C., Hu, G., Xie, G., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001166 · Cited by 11
Medical Nutrition Therapy for Diabetic Kidney Disease
Rhee, C. M., Kalantar‐Zadeh, K., & Moore, L. W. (2021) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2021.03.004 · Cited by 11
Self-citationDiagnosis 101: diabetic kidney disease
Lerma, E. V. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac163 · Cited by 11
Chuang, G., Kremer, D., Huang, C.-H., Alkaff, F. F., Lin, C., Tseng, T., Laverman, G. D., Bakker, S. J. L., & Chuang, L. (2023) · American Journal of Nephrology · doi:10.1159/000534514 · Cited by 10
Hadjadj, S., Cooper, M. E., Steubl, D., Petrini, M., Hantel, S., Mattheus, M., Wanner, C., & Thomas, M. C. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2023.100783 · Cited by 10
Knowler, W. C., Chen, H., Bahnson, J. L., Kahn, S. E., Lewis, C. E., Nathan, D. M., Nelson, R. G., Pilla, S. J., & Bantle, J. P. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004079 · Cited by 10
Vianini, E., Pandey, A., Rolland, C., Ngubane, N., Müller‐Wieland, D., Gilbert, J. D., & Alhussein, A. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01725-8 · Cited by 10
Mu, H., Zhang, Q., Huang, W., Pan‐Hammarström, Q., Zhang, Y., Lu, Y., Zhu, Z., Jiang, X., Wang, G., Zheng, M., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1584049 · Cited by 10
Implementing a pharmacist-led transition of care model for posttransplant hyperglycemia
Do, V., Haakinson, D. J., Belfort‐DeAguiar, R., & Cohen, E. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab151 · Cited by 10
Zhang, D., Liu, W., Peng, L. J., Wang, H., Mei, L., Li, Y., & Wang, Z. (2022) · BMC Oral Health · doi:10.1186/s12903-021-01985-3 · Cited by 10
Alterations in plantar vessel blood flow in patients with mild diabetic peripheral neuropathy
Zhou, Q., Qian, Z., Yang, M., Liu, J., Wu, J., Ren, L., & Ren, L. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002492 · Cited by 10
Zhao, P., Li, N., Lin, L., Li, Q., Wang, Y., & Luo, Y. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2134026 · Cited by 10
Pantalone, K. M., Ji, X., Kong, S. X., Elliott, J., Milinovich, A., Misra‐Hebert, A. D., Farej, R., Singh, R., Bauman, J. M., Zimmerman, R. S., et al. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108418 · Cited by 10
Katsimardou, A., Patoulias, D., Zografou, I., Tegou, Z., Imprialos, K. P., Stavropoulos, K., Toumpourleka, M., Karagiannis, A. I., Petidis, K., & Doumas, M. N. (2023) · Medicina · doi:10.3390/medicina59050969 · Cited by 10
Tekalign, T., Guta, M. T., Awoke, N., Chichiabellu, T. Y., Meskele, M., Anteneh, G., Tura, T. S., & Workie, S. B. (2023) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s396574 · Cited by 10
Bae, J., & Lee, B. (2023) · Biomedicines · doi:10.3390/biomedicines11071928 · Cited by 10
Fan, Z., Cai, Q., Chen, Y., Meng, X., Cao, F., Zheng, S., & Guo, J. (2016) · Medicine · doi:10.1097/md.0000000000003087 · Cited by 10
Concepts in Diabetic Nephropathy: From Pathophysiology to Treatment
Kinaan, M., Yau, H., Martinez, S., & Kar, P. M. (2017) · Journal of Renal and Hepatic Disorders · doi:10.15586/jrenhep.2017.17 · Cited by 10
Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes
Schroeder, E. B., Chonchol, M., Shetterly, S. M., Powers, J. D., Adams, J., Schmittdiel, J. A., Nichols, G. A., O’Connor, P. J., & Steiner, J. F. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09510817 · Cited by 10
Hwang, Y., Kim, S. W., Hur, K. Y., Soo, B., Kim, I. J., Park, T. S., Baik, S. H., Yoon, K., Lee, K. W., Lee, I. K., et al. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e117 · Cited by 10
National Consensus Statement on the Management of Type 2 Diabetes Mellitus in Nepal
Shrestha, D., Shrestha, P. K., Sharma, S., Bhattarai, J., Shrestha, H. K., Pradhan, A., & Shakya, A. (2019) · Journal of Diabetes and Endocrine Association of Nepal · doi:10.3126/jdean.v3i1.24072 · Cited by 10
Chung, J. O., Park, S., Cho, D. H., Chung, D. J., & Chung, M. Y. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1017-3048 · Cited by 11
Takahashi, K., Nakamura, A., Furusawa, S., Yokozeki, K., Sugawara, H., Yanagisawa, H., Akikawa, K., & Kikuchi, H. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100244 · Cited by 10
Li, Y., Li, J., Yan, J. Y., Zhang, H., Zhang, R., & Hu, C. (2021) · Mediators of Inflammation · doi:10.1155/2021/5521050 · Cited by 10
Navarra, S. M., Solini, A., Baroni, M. G., Frova, L., & Grande, E. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-01132-9 · Cited by 10
Sharma, S. K., Thakur, K., Kant, R., & Mudgal, S. K. (2021) · Cureus · doi:10.7759/cureus.20436 · Cited by 10
Bargues‐Navarro, G., Valle, V. I.-D., Mlili, N. E., & Cauli, O. (2022) · Medicina · doi:10.3390/medicina58081091 · Cited by 10
Patorno, E., Gopalakrishnan, C., Bartels, D. B., Brodovicz, K. G., Liu, J., & Schneeweiss, S. (2018) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.5 · Cited by 9
de Boer, I. H., Zelnick, L. R., Lin, J., Schaumberg, D. A., Wang, L., RUZINSKI, J. T., Friedenberg, G., Duszlak, J., Bubes, V. Y., Hoofnagle, A. N., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.09.014 · Cited by 10
Heleniak, Z., Illersperger, S., Małgorzewicz, S., Dębska-Ślizień, A. M., Budde, K., & Halleck, F. (2022) · Transplantation Proceedings · doi:10.1016/j.transproceed.2022.07.007 · Cited by 9
Bian, X., Wang, C., Wang, M., Yin, A., Xu, J., Liu, M., Wang, H., Cao, Y., Huang, X., Qin, C., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1541440 · Cited by 9
Individualized Diets in Patients with Kidney Disease and Kidney Transplants: A Narrative Review
Hu, L., Borelli, G., Gessaroli, E., Ruotolo, C., Bin, S., Papalia, G., Patella, G., Liberti, M. E., Baraldi, O., Zaza, G., et al. (2025) · Life · doi:10.3390/life15060896 · Cited by 9
Santos, G. L., dos Santos, C. F., Rocha, G. R., Calmon, M. S., Lemos, F. F. B., Silva, L. G., Luz, M. S., Pinheiro, S. L. R., Botelho, A. C., & de Melo, F. F. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i6.104706 · Cited by 9
Wang, Y., Liu, X., & Xiao, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1564170 · Cited by 10
Cardiovascular manifestations of renovascular hypertension in diabetic mice
Kashyap, S., Engel, S., Osman, M., Al-Saiegh, Y., Wongjarupong, A., & Grande, J. P. (2016) · PeerJ · doi:10.7717/peerj.1736 · Cited by 9
Wang, Y., Han, M., Pedigo, C. E., Zhao, N., & Liu, J. (2020) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2020.101197 · Cited by 9
Li, Y., Zhang, Y., Shen, X., Zhao, F., & Yan, S. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5596125 · Cited by 9
The 100 top-cited articles in diabetic kidney disease: a bibliometric analysis
Huang, Z., Zhang, H., Luo, Y., Wei, C., Zhao, Y., Huang, Y., Zhang, L., Chen, W., He, L., Liu, H., et al. (2021) · Renal Failure · doi:10.1080/0886022x.2021.1919528 · Cited by 10
Metadata
- Authors
- Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., Neumiller, J. J., Patel, U. D., Ratner, R. E., Whaley-Connell, A. T., & Molitch, M. E.
- Affiliations
- University of Washington (US)
- National Kidney Foundation (US)
- Newcastle University (GB)
- American Diabetes Association (US)
- Division of Nephrology, University of Washington, Seattle, WA
- Sierra Nevada Nephrology Consultants, Reno, NV
- School of Medicine, University of California, Irvine, Irvine, CA
- National Institutes of Health (US)
- Cleveland Clinic (US)
- Washington State University Spokane (US)
- Duke University (US)
- Harry S. Truman Memorial Veterans Hospital, Columbia, MO, and Department of Internal Medicine, Division of Nephrology and Hypertension, University of Missouri School of Medicine, Columbia, MO
- Northwestern University (US)
- Corresponding author
- Chiang, Jane L.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-09-10
- Volume
- 37
- Issue
- 10
- Pages
- 2864-2883
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC4170131
- OpenAlex
- W2072070798
- Semantic Scholar
- 0c6864a569d8918ea51eda33aae122cff819ac65
- Cited by
- 1,153
- References
- 193
- Citations by year
- 2026: 90 · 2025: 104 · 2024: 107 · 2023: 131 · 2022: 128 · 2021: 118 · 2020: 130 · 2019: 87 · 2018: 87 · 2017: 72 · 2016: 65 · 2015: 27 · 2014: 6
- FWCI
- 44.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Gilead Sciences
- Halozyme
- Luitpold Pharmaceuticals
- Angion
- Novo Nordisk
- CSL Limited
- National Institutes of Health (UL1TR000430)
- Relypsa
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- diabetic nephropathy, end-stage renal disease, type 2 diabetes, chronic kidney disease, cardiovascular disease, dyslipidemia, hypertension, renin-angiotensin-aldosterone system blockade, mineralocorticoid receptor antagonists, glycemic control, hypoglycemia, pharmacotherapy, pediatric diabetes, multidisciplinary care, patient-centered medical home, health care delivery
- MeSH terms
- Adolescent, Aged, Antihypertensive Agents, Blood Glucose, Cardiovascular Diseases, Child, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Humans, Kidney Function Tests, Middle Aged, Incidence, Prevalence, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
